NeuroScientific Biopharmaceuticals Ltd
NSB.AX ✗ NOT COMPLIANTFree checks used up today ☆ Track — members
ASX
·
Healthcare
·
Biotechnology & Medical Research
·
Last Close
$0.03
▲ +0.00%
Price charts are for members
Interactive price history from intraday to 5 years, on every stock and ETF.
See plans
Key Metrics
P/E Ratio
N/A
FWD: N/A
Market Cap
$13.63M
Micro Cap
Div Yield
0.00%
Annual dividend
EPS Growth
N/A
YoY
RSI (14)
37.50
Momentum
Beta
1.90
vs Market
52W High
$0.13
70.91% below
52W Low
$0.03
21.60% above
Volume
160.51K
Avg 101.22K
P/B
1.55
Price-to-book
ROE
N/A
Return on equity
Free Float
54.79%
Public shares
Historical Returns
5D
-7.41%
1M
-13.79%
3M
-16.67%
6M
-52.38%
YTD
-54.55%
1Y
-65.52%
3Y
-7.99%
5Y
-85.29%
Financials & Valuation
TTM · Annual
| Total Revenue | $435.48K |
| Net Income | $-3,247,187.00 |
| Revenue Growth (YoY) | +172.22% |
| Gross Margin | 100.00% |
| Operating Margin | -711.56% |
| Net Profit Margin | -745.66% |
| ROE | N/A |
| ROA · ROIC | -29.20% · N/A |
| P/E Ratio | N/A |
| Forward P/E (FY1) | N/A |
| PEG Ratio | N/A |
| P/S | 31.62 |
| P/B | 1.55 |
| P/FCF | N/A |
| EPS Growth | N/A |
| Outstanding Shares | 389.72M |
Technical Indicators
| 50-Day SMA | $0.04 |
| 200-Day SMA | $0.06 |
| RSI (14) | 37.50 |
| Beta | 1.90 |
| 52-Week High | $0.13 |
| 52-Week Low | $0.03 |
| Volume Today | 160.51K |
| Avg Daily Volume (30D) | 101.22K |
| Relative Volume | 1.59x |
| Volatility (10D) | 54.75 |
| Volatility (30D) | 58.69 |
| Free Float | 54.79% |
